Stay updated on Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer now displays Revision: v3.5.5, replacing the previous Revision: v3.5.4.
    Difference
    0.0%
    Check dated 2026-06-08T15:16:03.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.4 in place of Revision: v3.5.3, indicating a new site software release. This update affects page labeling but not the underlying study information.
    Difference
    0.0%
    Check dated 2026-05-18T03:49:31.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    This updates the page’s revision/version label from **v3.5.2** to **v3.5.3** in the footer, indicating a minor site maintenance change rather than a change to the underlying trial information.
    Difference
    0.0%
    Check dated 2026-04-26T13:30:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added revision: v3.5.2. Removed revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-19T04:46:55.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Revision: v3.5.0 added. The previous Revision: v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-21T08:44:57.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:15.000Z thumbnail image

Stay in the know with updates to Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenvatinib Plus Pembrolizumab in Melanoma Clinical Trial page.